Best practice in primary care pathology: Review 11

Journal of Clinical Pathology

Volumn 61, Issue 4, 2008, Pages 410-418

  Smellie, W S A ^a   Vanderpump, M P J ^b   Fraser, W D ^c   Bowley, R ^d   Shaw, N ^d  

^a BISHOP AUCKLAND GENERAL HOSPITAL   (United Kingdom)

^b ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d All Saints Business Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA INTERFERON; AMIODARONE; ANTACID AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CARBAMAZEPINE; CARBIMAZOLE; CISPLATIN; COLESTIPOL; COLESTYRAMINE; CORTICOSTEROID; CYTOSINE; DOPAMINE; DOXORUBICIN; FERROUS SULFATE; FUROSEMIDE; HEPARIN; IODINATED CONTRAST MEDIUM; IODINE DERIVATIVE; LEVODOPA; LITHIUM; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYTOIN; PROTON PUMP INHIBITOR; RIFAMPICIN; RITONAVIR; SUCRALFATE; THYROXINE; UNINDEXED DRUG;

CLINICAL PRACTICE; CLINICAL TRIAL; DIAGNOSTIC TEST; DOSE RESPONSE; DRUG MECHANISM; DRUG MEGADOSE; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; HYPERTHYROIDISM; HYPOCALCEMIA; HYPOTHYROIDISM; LABORATORY TEST; MEDICAL INFORMATION; MEDICAL LITERATURE; MEDICAL RESEARCH; PRACTICE GUIDELINE; PREGNANCY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; THYROID CANCER; THYROID FUNCTION TEST;

EVIDENCE-BASED MEDICINE; HUMANS; HYPERCALCEMIA; HYPOCALCEMIA; PATIENT SELECTION; PRIMARY HEALTH CARE; THYROID DISEASES; THYROID FUNCTION TESTS;

EID: 42049085044     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2007.052738     Document Type: Review

References (33)

1. Association for Clinical Biochemistry, British Thyroid Association. British Thyroid Foundation UK guidelines for the use of thyroid function tests 2006. http://www.acb.org.uk/docs/TFTguidelinefinal.pdf (accessed 15 January 2008).
2. Ball R, Freedman DB, Holmes JC, et al. Lower serum free thyroxine in late pregnancy; physiological fact not technical artefact. Clin Chem 1989;35:1891-6.
3. Endres DB, Rude RK. Mineral and bone metabolism. In: Burtis CA, Ashwood ER, eds. Tietz textbook of clinical chemistry. 3rd edn. Philadelphia: Saunders, 1999: 1395-1457.
4. DynaMed Hypercalcemia. EBSCO Publishing 2006. http://www. ebscohost.com/dynamed (subscription website, accessed 15 January 2008).
5. Hemphill RR. Hypercalcemia. 2006. WebMD. http://www.emedicine.com (accessed 15 January 2008).
6. Bilezikian JP. Management of hypercalcemia. J Clin Endocrinol Metab 1993;77:1445-9.
7. Carroll MF, Schade DS. A practical approach to hypercalcemia. Am Fam Physician 2003;67:1959-66.
8. Weiss-Guillet EM, Takala J, Jakob SM. Diagnosis and management of electrolyte emergencies. Best Pract Res Clin Endocrinol Metabol 2003;17:623-51.
9. Alberta Medical Association. Laboratory endocrine testing guidelines: hypercalcemia. Alberta Clinical Practice Guidelines, Alberta Medical Association. 2006. http://www.topalbertadoctors.org (accessed 15 January 2008).
10. Pearce CJ, Hine TJ, Peek K. Hypercalcemia due to calcium binding by a polymeric IgA Kappa paraprotein. Ann Clin Biochem 1991;28:229-34.
11. Lippi G, Salvagno GL, Montagnana M, et al. Influence of short-term venous stasis on clinical chemistry testing. Clin Chem Lab Med 2005;43:869-75.
12. McMullan AD, Burns J, Paterson CR. Venepuncture for calcium assays: should we still avoid the tourniquet? Postgrad Med J 1990 July;66:547-8.
13. Gutteridge DH, Gruber HE, Kermode DG, et al. Thirty cases of concurrent Paget's disease and primary hyperparathyroidism: sex distribution, histomorphometry, and prediction of the skeletal response to parathyroidectomy. Calcif Tissue Int 1999 December;65:427-35.
14. Mundy GR, Martin TJ. The hypercalcemia of malignancy: pathogenesis and management. Metabolism 1982;31:1247-77.
15. The Royal College of Pathologists of Australasia. RCPA manual. Hypocalcaemia version 4.0. 2004. http://www.rcpamanual.edu.au/sections/ clinicalproblem.asp?s=25&i=352 (accessed: 15 January 2008).
16. Bilezikian JP, Potts JT Jr, Fuleihan G, et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Bone Miner Res 2002;17:N2-11.
17. Gunn IR, Gaffney D. Clinical and laboratory features of calcium-sensing receptor disorders: a systematic review. Ann Clin Biochem 2004;41:441-58.
18. Smellie WSA, Wilson D, McNulty CAM, et al. Best practice in primary care pathology: review 1. J Clin Pathol 2005;58:1016-24.
19. Smellie WSA, Forth J, McNulty CAM, et al. Best practice in primary care pathology: review 2 J Clin Pathol 2006;59:113-20.
20. Smellie WSA, Forth JO, Bareford D, et al. Best practice in primary care pathology: review 3. J Clin Pathol 2006;59:781-9.
21. Smellie WSA, Forth J, Sundar S, et al. Best practice in primary care pathology: review 4 J Clin Pathol 2006;59:893-902.
22. Smellie WSA, Forth J, Ryder S, et al. Best practice in primary care pathology: review 5 J Clin Pathol 2006;59:1229-37.
23. Smellie WSA, Forth J, Coleman J, et al. Best practice in primary care pathology. Review 6 J Clin Pathol 2007;60:225-34.
24. Smellie WSA, Forth J, Smart SRS, et al. Best practice in primary care pathology: review 7. J Clin Pathol 2007;60:458-65.
25. Smellie WSA, Bowley R, Shaw N, et al. Best practice in primary care pathology: review 8. J Clin Pathol 2007;60:740-8.
26. Smellie WSA, Shaw N, Bowley R, et al. Best practice in primary care pathology: review 9. J Clin Pathol 2007;60:966-75.
27. Smellie WSA, Shaw N, Bowley R, et al. Best practice in primary care pathology: review 10. J Clin Pathol 2007;60:1195-204.
28. Smellie WSA, Wilson D, Finnegan DI, et al. Best practice in pathology. Methodology for constructing guidance. J Clin Path 2005;58:249-53.
29. General Medical Services Contract. http://www.dh.gov.uk/en/ policyandguidance/organisationpolicy/primarycare/primarycarecontracting/gms/ dh_4125636 (accessed 23 January 2008).
30. NHS Confederation. Quality and outcomes framework. http://www.dh.gov.uk/en/policyandguidance/organisationpolicy/primarycare/ primarycarecontracting/QOF/index.htm (accessed 15 January 2008).
31. Revisions to the GMS contract 2006/7. http://www.nhsemployers.org/ primary/index.cfm (accessed 15 January 2008).
32. Demers LM, Spencer CA. NACB: Laboratory support for the diagnosis and monitoring of thyroid disease. Clin Endocrinol 2003;53:138-40.
33. Dong BJ. How medications affect thyroid function. West J Med 2000;172:102-6.